Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Short Interest Update

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 108,604 shares, a drop of 36.5% from the January 29th total of 170,972 shares. Based on an average daily trading volume, of 161,429 shares, the short-interest ratio is currently 0.7 days. Currently, 0.3% of the company’s shares are short sold. Currently, 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 161,429 shares, the short-interest ratio is currently 0.7 days.

Neuberger Berman High Yield Strategies Fund Price Performance

NHS traded down $0.01 during mid-day trading on Friday, hitting $7.72. 166,039 shares of the stock were exchanged, compared to its average volume of 149,229. The firm’s fifty day moving average is $7.48 and its two-hundred day moving average is $7.43. Neuberger Berman High Yield Strategies Fund has a 1-year low of $6.62 and a 1-year high of $7.94.

Neuberger Berman High Yield Strategies Fund Announces Dividend

The firm also recently announced a monthly dividend, which was paid on Friday, February 27th. Shareholders of record on Tuesday, February 17th were issued a dividend of $0.0905 per share. The ex-dividend date was Tuesday, February 17th. This represents a c) dividend on an annualized basis and a yield of 14.1%.

Institutional Trading of Neuberger Berman High Yield Strategies Fund

A number of large investors have recently modified their holdings of NHS. XTX Topco Ltd purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 2nd quarter worth about $113,000. J.W. Cole Advisors Inc. increased its stake in shares of Neuberger Berman High Yield Strategies Fund by 3.1% during the second quarter. J.W. Cole Advisors Inc. now owns 206,192 shares of the investment management company’s stock worth $1,563,000 after buying an additional 6,237 shares during the period. Invesco Ltd. raised its holdings in Neuberger Berman High Yield Strategies Fund by 3.5% in the second quarter. Invesco Ltd. now owns 258,944 shares of the investment management company’s stock valued at $1,963,000 after acquiring an additional 8,676 shares in the last quarter. StoneX Group Inc. purchased a new position in Neuberger Berman High Yield Strategies Fund in the second quarter worth approximately $296,000. Finally, Balyasny Asset Management L.P. acquired a new position in Neuberger Berman High Yield Strategies Fund during the 2nd quarter worth approximately $338,000.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.